Evercore ISI Cuts DENTSPLY SIRONA (NASDAQ:XRAY) Price Target to $27.00

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target reduced by Evercore ISI from $28.00 to $27.00 in a research note published on Tuesday, Benzinga reports. Evercore ISI currently has an outperform rating on the medical instruments supplier’s stock.

Several other equities research analysts also recently weighed in on XRAY. Barrington Research restated an outperform rating and issued a $38.00 target price on shares of DENTSPLY SIRONA in a research note on Monday. Piper Sandler restated a neutral rating and issued a $32.00 target price (down from $35.00) on shares of DENTSPLY SIRONA in a research note on Friday, May 3rd. Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating for the company in a research note on Friday, May 3rd. The Goldman Sachs Group lowered their target price on shares of DENTSPLY SIRONA from $34.00 to $30.00 and set a neutral rating for the company in a research note on Monday, May 6th. Finally, Needham & Company LLC lowered their target price on shares of DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating for the company in a research note on Friday, May 3rd. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, DENTSPLY SIRONA presently has an average rating of Moderate Buy and an average price target of $34.33.

DENTSPLY SIRONA Stock Up 5.3 %

Shares of XRAY stock opened at $25.71 on Tuesday. The company’s 50 day moving average is $26.72 and its 200 day moving average is $31.13. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.43 and a quick ratio of 0.97. DENTSPLY SIRONA has a 52-week low of $23.94 and a 52-week high of $41.65.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.42. The company had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. DENTSPLY SIRONA had a negative net margin of 2.41% and a positive return on equity of 11.54%. DENTSPLY SIRONA’s revenue was down 2.6% compared to the same quarter last year. During the same period last year, the company posted $0.39 earnings per share. As a group, analysts predict that DENTSPLY SIRONA will post 2.02 earnings per share for the current fiscal year.

DENTSPLY SIRONA Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Stockholders of record on Friday, June 28th will be paid a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, June 28th. This represents a $0.64 annualized dividend and a dividend yield of 2.49%. DENTSPLY SIRONA’s payout ratio is currently -145.45%.

Insider Activity at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 3,577 shares of the firm’s stock in a transaction that occurred on Friday, May 31st. The stock was bought at an average cost of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the transaction, the director now directly owns 58,374 shares of the company’s stock, valued at approximately $1,631,553.30. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.52% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the business. Vanguard Group Inc. lifted its position in DENTSPLY SIRONA by 1.5% during the third quarter. Vanguard Group Inc. now owns 25,250,443 shares of the medical instruments supplier’s stock valued at $862,555,000 after purchasing an additional 369,213 shares during the period. Nuance Investments LLC increased its holdings in DENTSPLY SIRONA by 30.4% in the fourth quarter. Nuance Investments LLC now owns 11,603,889 shares of the medical instruments supplier’s stock valued at $412,982,000 after buying an additional 2,702,457 shares in the last quarter. First Eagle Investment Management LLC increased its holdings in DENTSPLY SIRONA by 1.2% in the fourth quarter. First Eagle Investment Management LLC now owns 9,786,845 shares of the medical instruments supplier’s stock valued at $348,314,000 after buying an additional 120,508 shares in the last quarter. Wellington Management Group LLP increased its holdings in DENTSPLY SIRONA by 21.1% in the fourth quarter. Wellington Management Group LLP now owns 8,138,253 shares of the medical instruments supplier’s stock valued at $289,640,000 after buying an additional 1,419,503 shares in the last quarter. Finally, Cooke & Bieler LP increased its holdings in DENTSPLY SIRONA by 18.3% in the fourth quarter. Cooke & Bieler LP now owns 7,061,910 shares of the medical instruments supplier’s stock valued at $251,333,000 after buying an additional 1,092,922 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.